Professional Organizations
UCB Resources for Healthcare Professionals
Courses and CME
UCB Resources for Patients
Other Patient Resources
Professional Organizations
American Academy of Neurology (AAN)
The AAN is an international professional association of neurologists and neuroscience professionals dedicated to providing the best
possible care for patients with neurological disorders.
www.aan.com
American Epilepsy Society (AES)
The AES promotes research and education for professionals dedicated to the prevention, treatment, and cure of epilepsy.
www.aesnet.org
International League Against Epilepsy (ILAE)
The mission of the ILAE is to provide the highest quality of care and well-being for patients with epilepsy and related seizure disorders.
www.ilae-epilepsy.org
National Association of Epilepsy Centers (NAEC)
With the goal of no seizures and no side effects, the NAEC educates public and private policymakers and regulators about appropriate patient care standards, reimbursement, and medical services policies.
www.naec-epilepsy.org
UCB Resources for Healthcare Professionals
State Generic Guidelines Flashcard
A quick-reference chart of state-specific requirements for generic substitution and guidance on writing prescriptions to ensure that antiepileptic drugs are dispensed as prescribed.
Download the State Generic Guidelines Flashcard (PDF 88 KB)
To do so, you need Adobe® Reader®.
If you do not have Adobe Reader, you can download it for free.
UCB AED Pregnancy Registry
UCB, Inc. has established the UCB AED Pregnancy Registry to advance scientific knowledge about safety and outcomes associated with pregnant women being treated with any epilepsy medications from UCB, including Keppra® (levetiracetam) and Keppra XR®. To ensure broad program access and reach, either a healthcare provider or the patient can initiate enrollment in the Keppra Pregnancy Registry by calling (888) 537-7734 (toll free). Patients may also enroll in the North American Antiepileptic Drug Pregnancy Registry by calling (888) 233-2334 (toll free).
Courses and CME
Neurology Residents Scholarship Program (NRSP)
An intensive 2-day course addressing clinical aspects of epilepsy for second- and third-year neurology residents.
www.nrsponline.com
American Academy of Neurology CME
Online CME from the journal Neurology.
intl-cme.neurology.org/cgi/hierarchy/aancme_node;neurology2008
Doctors’ Guide CME
Provides links to online CME activities, which can be sorted by specialty.
www.docguide.com
Epilepsy.com CME
A variety of online epilepsy-related CME activities.
professionals.epilepsy.com/secondary/continuing_medical_education.html
Medscape CME
A listing of online CME offerings within the Medscape Epilepsy Resource Center.
www.medscape.com/resource/epilepsy/rc-epilepsy3 (registration required)
UCB Resources for Patients
Epilepsy Advocate
Epilepsy Advocates are a community of people and their families living with epilepsy. The site includes inspiring stories and interactive video diaries as well as practical advice, Webcasts, monthly e-mails, and a magazine.
www.epilepsyadvocate.com
Epilepsy Advocate L.I.V.E. Events
Epilepsy Advocate Learn from Inspiring Voices with Epilepsy (L.I.V.E.) events offer a chance for people with epilepsy to connect with the local epilepsy community. Each event features inspiring personal stories; information from physician experts about epilepsy, current treatments, and medications; and a Q&A session.
www.epilepsyadvocate.com/events/events.aspx
Epilepsy Classroom®
Created by pediatric neurologist G. Dean Timmons, MD, and Associate Professor Beverly Timmons, EdD, Epilepsy Classroom features tools and resources to help students, teachers, and parents understand epilepsy, know how to respond to seizures, and to feel comfortable talking about it.
www.epilepsyclassroom.com
UCB AED Pregnancy Registry
UCB, Inc. has established the UCB AED Pregnancy Registry to advance scientific knowledge about safety and outcomes associated with pregnant women being treated with any epilepsy medications from UCB, including Keppra® and Keppra XR®. To ensure broad program access and reach, either a healthcare provider or the patient can initiate enrollment in the Keppra Pregnancy Registry by calling (888) 537-7734 (toll free). Patients may also enroll in the North American Antiepileptic Drug Pregnancy Registry by calling (888) 233-2334 (toll free).
The UCB Family Epilepsy Scholarship Program®
The UCB Family Epilepsy Scholarship Program® provides financial support to encourage academic and personal achievement not just to people with epilepsy, but also to the family members and caregivers who contribute to their successes. UCB, Inc. awards thirty $5,000 scholarships a year, and since 2005, has awarded over half a million dollars in scholarships.
www.epilepsyadvocate.com/resources/scholarship.aspx
Other Patient Resources
Canine Assistants Program
Canine Assistants is a non-profit organization that provides service dogs for children and adults with physical disabilities or other special needs, including epilepsy.
www.canineassistants.org
Epilepsy Foundation H.O.P.E. Mentoring Program
The H.O.P.E. Mentoring Program (Helping Other People with Epilepsy) was created to allow people who live with epilepsy to educate others and share their experiences. This educational program trains people with epilepsy to be “patient educators” throughout the epilepsy and neurology communities.
www.epilepsyfoundation.org/programs/hope.cfm
Epilepsy Classroom and UCB Family Epilepsy Scholarship Program are trademarks of the UCB Group of Companies.
IMPORTANT SAFETY INFORMATION
Keppra XR® extended-release tablets are indicated as adjunctive therapy in
the treatment of partial onset seizures in patients 16 years of age and older with epilepsy.
Antiepileptic drugs (AEDs) increase the risk of suicidal thoughts or behavior in patients
taking these drugs for any indication. Patients treated with any AED for any indication should
be monitored for the emergence or worsening of depression, suicidal thoughts or behavior,
and/or any unusual changes in mood or behavior. Keppra XR® causes somnolence,
dizziness, and behavioral abnormalities. The most common adverse reactions observed with
Keppra XR® in combination with other AEDs were somnolence and irritability.
The adverse reactions that may be seen in patients receiving Keppra XR® are expected to be
similar to those seen in patients receiving immediate-release Keppra® (levetiracetam) tablets.
Keppra® immediate-release tablets cause somnolence and fatigue, coordination difficulties,
and behavioral abnormalities (e.g., psychotic symptoms, suicidal ideation, and other
abnormalities), as well as hematological abnormalities. In adults experiencing partial onset
seizures, the most common adverse reactions observed with Keppra® in combination with
other AEDs were somnolence, asthenia, infection, and dizziness.
Keppra XR® should be gradually withdrawn to minimize the potential of increased seizure
frequency.
Dosing must be individualized according to the patient’s renal function status. In patients
with end stage renal disease on dialysis, it is recommended that immediate-release Keppra®
be used instead of Keppra XR®. Please see Keppra.com for the Keppra® immediate-release
tablets full prescribing information.
Please see Keppra XR® Medication Guide and Full Prescribing
Information.